Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

OSUR vs HOLX vs BDX vs QDEL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OSUR
OraSure Technologies, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$225M
5Y Perf.-78.5%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%
BDX
Becton, Dickinson and Company

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$55.53B
5Y Perf.+3.0%
QDEL
QuidelOrtho Corporation

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$733M
5Y Perf.-93.8%

OSUR vs HOLX vs BDX vs QDEL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OSUR logoOSUR
HOLX logoHOLX
BDX logoBDX
QDEL logoQDEL
IndustryMedical - Instruments & SuppliesMedical - Instruments & SuppliesMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$225M$16.97B$55.53B$733M
Revenue (TTM)$85M$4.13B$21.36B$2.66B
Net Income (TTM)$-53M$544M$1.14B$-1.21B
Gross Margin38.8%52.8%46.5%56.6%
Operating Margin-58.6%17.5%10.6%-37.0%
Forward P/E17.2x12.3x6.4x
Total Debt$13M$2.63B$19.18B$2.80B
Cash & Equiv.$199K$1.96B$851M$170M

OSUR vs HOLX vs BDX vs QDELLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OSUR
HOLX
BDX
QDEL
StockMay 20May 26Return
OraSure Technologie… (OSUR)10021.5-78.5%
Hologic, Inc. (HOLX)100142.6+42.6%
Becton, Dickinson a… (BDX)100103.0+3.0%
QuidelOrtho Corpora… (QDEL)1006.2-93.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: OSUR vs HOLX vs BDX vs QDEL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HOLX and BDX are tied at the top with 3 categories each — the right choice depends on your priorities. Becton, Dickinson and Company is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. QDEL also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
OSUR
OraSure Technologies, Inc.
The Income Pick

OSUR is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.45
Best for: income & stability
HOLX
Hologic, Inc.
The Long-Run Compounder

HOLX carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 124.3% 10Y total return vs BDX's 80.2%
  • Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
  • Beta 0.41, current ratio 3.75x
  • 13.2% margin vs OSUR's -61.9%
Best for: long-term compounding and sleep-well-at-night
BDX
Becton, Dickinson and Company
The Growth Play

BDX is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
  • 8.2% revenue growth vs OSUR's -38.1%
  • 2.7% yield; 1-year raise streak; the other 3 pay no meaningful dividend
  • +51.8% vs QDEL's -58.3%
Best for: growth exposure
QDEL
QuidelOrtho Corporation
The Value Play

QDEL is the clearest fit if your priority is value.

  • Lower P/E (6.4x vs 12.3x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthBDX logoBDX8.2% revenue growth vs OSUR's -38.1%
ValueQDEL logoQDELLower P/E (6.4x vs 12.3x)
Quality / MarginsHOLX logoHOLX13.2% margin vs OSUR's -61.9%
Stability / SafetyHOLX logoHOLXBeta 0.41 vs QDEL's 2.59, lower leverage
DividendsBDX logoBDX2.7% yield; 1-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)BDX logoBDX+51.8% vs QDEL's -58.3%
Efficiency (ROA)HOLX logoHOLX6.1% ROA vs QDEL's -20.7%, ROIC 9.4% vs -13.6%

OSUR vs HOLX vs BDX vs QDEL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OSUROraSure Technologies, Inc.
FY 2025
Product And Services
94.8%$109M
Other Revenues
5.2%$6M
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M
BDXBecton, Dickinson and Company
FY 2025
Medical
52.5%$11.5B
Interventional
23.9%$5.2B
Life Sciences
23.7%$5.2B
QDELQuidelOrtho Corporation
FY 2023
Other
100.0%$483M

OSUR vs HOLX vs BDX vs QDEL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHOLXLAGGINGQDEL

Income & Cash Flow (Last 12 Months)

HOLX leads this category, winning 5 of 6 comparable metrics.

BDX is the larger business by revenue, generating $21.4B annually — 251.0x OSUR's $85M. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to OSUR's -61.9%. On growth, HOLX holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
RevenueTrailing 12 months$85M$4.1B$21.4B$2.7B
EBITDAEarnings before interest/tax-$45M$974M$4.2B-$649M
Net IncomeAfter-tax profit-$53M$544M$1.1B-$1.2B
Free Cash FlowCash after capex-$33M$1000M$3.1B-$75M
Gross MarginGross profit ÷ Revenue+38.8%+52.8%+46.5%+56.6%
Operating MarginEBIT ÷ Revenue-58.6%+17.5%+10.6%-37.0%
Net MarginNet income ÷ Revenue-61.9%+13.2%+5.3%-45.6%
FCF MarginFCF ÷ Revenue-38.9%+24.2%+14.7%-2.8%
Rev. Growth (YoY)Latest quarter vs prior year-99.9%+2.5%-10.6%-10.5%
EPS Growth (YoY)Latest quarter vs prior year-52.4%-9.2%-2.0%-6.1%
HOLX leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

QDEL leads this category, winning 3 of 6 comparable metrics.

At 26.3x trailing earnings, BDX trades at a 14% valuation discount to HOLX's 30.5x P/E. On an enterprise value basis, BDX's 14.7x EV/EBITDA is more attractive than HOLX's 17.4x.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
Market CapShares × price$225M$17.0B$55.5B$733M
Enterprise ValueMkt cap + debt − cash$238M$17.6B$73.9B$3.4B
Trailing P/EPrice ÷ TTM EPS-3.33x30.53x26.29x-0.65x
Forward P/EPrice ÷ next-FY EPS est.17.21x12.27x6.45x
PEG RatioP/E ÷ EPS growth rate1.59x
EV / EBITDAEnterprise value multiple17.39x14.65x
Price / SalesMarket cap ÷ Revenue1.96x4.14x2.54x0.27x
Price / BookPrice ÷ Book value/share0.67x3.43x1.73x0.38x
Price / FCFMarket cap ÷ FCF18.44x20.80x
QDEL leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

HOLX leads this category, winning 6 of 9 comparable metrics.

HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-56 for QDEL. OSUR carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to QDEL's 1.46x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs OSUR's 3/9, reflecting strong financial health.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
ROE (TTM)Return on equity-15.1%+11.0%+4.5%-56.3%
ROA (TTM)Return on assets-12.8%+6.1%+2.1%-20.7%
ROICReturn on invested capital-20.0%+9.4%+4.3%-13.6%
ROCEReturn on capital employed-16.8%+8.8%+5.4%-18.0%
Piotroski ScoreFundamental quality 0–93776
Debt / EquityFinancial leverage0.04x0.52x0.76x1.46x
Net DebtTotal debt minus cash$13M$667M$18.3B$2.6B
Cash & Equiv.Liquid assets$199,278$2.0B$851M$170M
Total DebtShort + long-term debt$13M$2.6B$19.2B$2.8B
Interest CoverageEBIT ÷ Interest expense8.00x4.09x-5.18x
HOLX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BDX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in BDX five years ago would be worth $11,693 today (with dividends reinvested), compared to $891 for QDEL. Over the past 12 months, BDX leads with a +51.8% total return vs QDEL's -58.3%. The 3-year compound annual growth rate (CAGR) favors BDX at 1.6% vs QDEL's -50.4% — a key indicator of consistent wealth creation.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
YTD ReturnYear-to-date+31.5%+1.9%+0.7%-62.6%
1-Year ReturnPast 12 months+12.2%+37.1%+51.8%-58.3%
3-Year ReturnCumulative with dividends-55.2%-8.5%+5.0%-87.8%
5-Year ReturnCumulative with dividends-68.3%+15.8%+16.9%-91.1%
10-Year ReturnCumulative with dividends-53.1%+124.3%+80.2%-34.9%
CAGR (3Y)Annualised 3-year return-23.5%-2.9%+1.6%-50.4%
BDX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

HOLX leads this category, winning 2 of 2 comparable metrics.

HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than QDEL's 2.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs QDEL's 27.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
Beta (5Y)Sensitivity to S&P 5001.45x0.41x0.66x2.59x
52-Week HighHighest price in past year$3.82$76.04$205.52$38.99
52-Week LowLowest price in past year$2.08$52.81$100.31$10.22
% of 52W HighCurrent price vs 52-week peak+81.9%+100.0%+74.6%+27.6%
RSI (14)Momentum oscillator 0–10047.169.132.235.2
Avg Volume (50D)Average daily shares traded473K10.0M2.5M2.2M
HOLX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

OSUR leads this category, winning 1 of 1 comparable metric.

Analyst consensus: OSUR as "Hold", HOLX as "Hold", BDX as "Buy", QDEL as "Buy". Consensus price targets imply 57.8% upside for QDEL (target: $17) vs 3.9% for HOLX (target: $79). BDX is the only dividend payer here at 2.72% yield — a key consideration for income-focused portfolios.

MetricOSUR logoOSUROraSure Technolog…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…QDEL logoQDELQuidelOrtho Corpo…
Analyst RatingConsensus buy/hold/sellHoldHoldBuyBuy
Price TargetConsensus 12-month target$4.00$79.00$172.85$17.00
# AnalystsCovering analysts13423315
Dividend YieldAnnual dividend ÷ price+2.7%
Dividend StreakConsecutive years of raises210
Dividend / ShareAnnual DPS$4.17
Buyback YieldShare repurchases ÷ mkt cap+6.7%+4.4%+1.8%0.0%
OSUR leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HOLX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). QDEL leads in 1 (Valuation Metrics).

Best OverallHologic, Inc. (HOLX)Leads 3 of 6 categories
Loading custom metrics...

OSUR vs HOLX vs BDX vs QDEL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OSUR or HOLX or BDX or QDEL a better buy right now?

For growth investors, Becton, Dickinson and Company (BDX) is the stronger pick with 8.

2% revenue growth year-over-year, versus -38. 1% for OraSure Technologies, Inc. (OSUR). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate Becton, Dickinson and Company (BDX) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OSUR or HOLX or BDX or QDEL?

On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.

3x versus Hologic, Inc. at 30. 5x. On forward P/E, QuidelOrtho Corporation is actually cheaper at 6. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OSUR or HOLX or BDX or QDEL?

Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +16.

9%, compared to -91. 1% for QuidelOrtho Corporation (QDEL). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus OSUR's -53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OSUR or HOLX or BDX or QDEL?

By beta (market sensitivity over 5 years), Hologic, Inc.

(HOLX) is the lower-risk stock at 0. 41β versus QuidelOrtho Corporation's 2. 59β — meaning QDEL is approximately 530% more volatile than HOLX relative to the S&P 500. On balance sheet safety, OraSure Technologies, Inc. (OSUR) carries a lower debt/equity ratio of 4% versus 146% for QuidelOrtho Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — OSUR or HOLX or BDX or QDEL?

By revenue growth (latest reported year), Becton, Dickinson and Company (BDX) is pulling ahead at 8.

2% versus -38. 1% for OraSure Technologies, Inc. (OSUR). On earnings-per-share growth, the picture is similar: QuidelOrtho Corporation grew EPS 45. 4% year-over-year, compared to -261. 5% for OraSure Technologies, Inc.. Over a 3-year CAGR, BDX leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OSUR or HOLX or BDX or QDEL?

Hologic, Inc.

(HOLX) is the more profitable company, earning 13. 8% net margin versus -59. 8% for OraSure Technologies, Inc. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus -59. 2% for OSUR. At the gross margin level — before operating expenses — HOLX leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OSUR or HOLX or BDX or QDEL more undervalued right now?

On forward earnings alone, QuidelOrtho Corporation (QDEL) trades at 6.

4x forward P/E versus 17. 2x for Hologic, Inc. — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for QDEL: 57. 8% to $17. 00.

08

Which pays a better dividend — OSUR or HOLX or BDX or QDEL?

In this comparison, BDX (2.

7% yield) pays a dividend. OSUR, HOLX, QDEL do not pay a meaningful dividend and should not be held primarily for income.

09

Is OSUR or HOLX or BDX or QDEL better for a retirement portfolio?

For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

66), 2. 7% yield). QuidelOrtho Corporation (QDEL) carries a higher beta of 2. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BDX: +80. 2%, QDEL: -34. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OSUR and HOLX and BDX and QDEL?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

BDX pays a dividend while OSUR, HOLX, QDEL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

OSUR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Stocks Like

BDX

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 1.0%
Run This Screen
Stocks Like

QDEL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OSUR and HOLX and BDX and QDEL on the metrics below

Revenue Growth>
%
(OSUR: -99.9% · HOLX: 2.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.